Cytochrome P450 Oxidation
Cytochrome P450 Oxidation - Related Videos
01:28
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
0 Views •
2026
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
07:42
Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
0 Views •
Cited by 15 •
2011
In this protocol, we describe the direct cytoplasmic microinjection of cytochrome c protein into fibroblasts and primary sympathetic neurons. This technique allows for the introduction of cytochrome c protein into the cytoplasm of cells and mimics the release of cytochrome c from mitochondria, which occurs during apoptosis.
11:06
Encapsulating Cytochrome c in Silica Aerogel Nanoarchitectures without Metal Nanoparticles while Retaining Gas-phase Bioactivity
0 Views •
Cited by 1 •
2016
This procedure describes how to encapsulate cytochrome c (cyt. c) in silica (SiO2) sol-gels, process these gels to form bioaerogels, and use these bioaerogels to rapidly recognize nitric oxide (NO) through a gas-phase reaction. This type of protocol may aid in the future development of biosensors or other bioanalytical devices.
03:14
Oxidation Numbers
0 Views •
2020
In redox reactions, the transfer of electrons occurs between reacting species. Electron transfer is described by a hypothetical number called the oxidation number (or oxidation state). It represents the effective charge of an atom or element, which is assigned using a set of rules. Oxidation Number (Oxidation State) In the case of an ionic compound, oxidation numbers are assigned based on the number of electrons transferred between reacting species. For example, in the formation of calcium...
11:10
Respirometric Oxidative Phosphorylation Assessment in Saponin-permeabilized Cardiac Fibers
0 Views •
Cited by 32 •
2011
Saponin-permeabilized fiber preparation in conjunction with respirometric oxidative phosphorylation analysis provides integrative assessment of mitochondrial function. Mitochondrial respiration in physiological and pathological states can reflect various regulatory influences including mitochondrial interactions, morphology and biochemistry.
FAQs
Cytochrome P450 oxidation can change a compound’s biological behavior in more than one direction. It may reduce activity and promote clearance, alter toxicity, or generate an active product from an otherwise inactive prodrug. The same broad process also matters for carcinogen activation, so its consequence depends on the substrate being examined and the outcome being measured.
Differences in P450 activity can change how quickly an anticancer drug is modified and cleared. Those metabolic differences may alter the amount of active compound available, contributing to variation in treatment response and adverse effects. Consequently, P450 characterization provides a biochemical explanation for why the same therapy may not produce identical outcomes across cancer research settings.
The process can support drug activation when an anticancer prodrug requires metabolic conversion to become effective. In contrast, activation of some chemical carcinogens represents a harmful outcome that may contribute to cancer-related concerns. Recognizing this dual role helps researchers interpret P450 activity according to the compound involved rather than treating oxidation as uniformly beneficial or harmful.
Evaluating P450 activity helps characterize how a candidate anticancer compound may be modified, cleared, or associated with toxicity. These findings can inform drug development by identifying metabolic features relevant to activity and safety. They also provide a basis for examining whether the compound could participate in interactions with other anticancer agents or compounds.
P450 studies can help explain why patients or experimental systems differ in anticancer drug metabolism, treatment response, and adverse effects. By relating enzyme activity to these outcomes, researchers gain information relevant to individualized therapy. The approach does not focus only on whether a drug works, but also on how its metabolic handling may influence the overall therapeutic experience.
Researchers should consider how P450-mediated modification of an anticancer agent may influence its activity, clearance, or toxicity when another compound is present. Studying these relationships supports evaluation of interactions among anticancer drugs and other compounds. The resulting information can clarify changes in treatment response or adverse effects that would be difficult to interpret from either compound alone.